Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder.
The COVID-19 pandemic has taken a toll on everyone, and not just physically. Taking care of your mental health is important too, especially because no one knows when the crisis will end. The GOV.UK website shares this guidance on staying balanced during these uncertain times:
You Might Also Enjoy...
Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder.
Pain can be depressing, and depression creates and exacerbates pain. This cycle can be a dangerous one. In fact, people afflicted by chronic pain are three times more likely to develop psychiatric disorders (most often anxiety or mood disorders).
Depression is a mental disorder that both men and women struggle with. However, in the case of men, the disorder can look very differently that it looks in women.
Anyone that has had Chickenpox, even if it was all the way back in childhood, now lives with the risk of experiencing Shingles when they enter their later years. And what does that have to do with Fibromyalgia?!
If you or a loved one are still struggling with depression even on medication, you are not the only one!
Fibromyalgia is painful, difficult to diagnose and has limited treatment options. But there are always new drugs being developed! #Fibro #FibroATL #FibroAlpharetta #FibroOptions